• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Optinose

Perhaps Trump can forget about another White House run and come help Peter run the nose. Pretty sure that Trump couldn’t do worse. Stock is back under $3.00 and headed where it belongs..the basement!